Effects of rikkunshito on plasma cholecystokinin levels in healthy volunteers

Effects of rikkunshito on plasma cholecystokinin levels in healthy volunteers - Effects of rikkunshito on plasma cholecystokinin levels

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009632

Enrollment

Registered

2013-02-01

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Oral administration of rikkunshito (2.5g t.i.d) before meals for 2 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Selection criterion at enrollment 1)Subjects who are not in therapy 2)Asymptomatic person 3)Subjects who did not take rikkunshito 2 weeks before treatment of rikkunshito 4)Agreement to sigh an informed consent

Exclusion criteria

Exclusion criteria: 1)Subjects who have organic disorder 2)Subjects who are pregnant,considering pregnancy or lactating 3)Subjects considered inapproplriate by the study investigator

Design outcomes

Primary

Measure	Time frame
Changes of plasma CCK levels before and after treatment of rikkunshito	—

Countries

Japan

Contacts

Public ContactKoji Yakabi

Saitama Medical Center,Saitama Medical University Department of Gastroenterology and Hepatology

kjyakabi@saitama-med.ac.jp049-228-3741

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026